CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-16 | Snodgres Jon Chief Financial Officer | Sale | −5,647 | $200.00 | $1.1M | 29,325 |
| 2022-08-16 | Snodgres Jon Chief Financial Officer | Sale | −4,298 | $252.70 | $1.1M | 36,906 |
| 2022-08-16 | Snodgres Jon Chief Financial Officer | Sale | −2,400 | $253.16 | $608K | 34,506 |
| 2022-08-01 | Snodgres Jon Chief Financial Officer | Sale | −2,000 | $220.00 | $440K | 37,187 |
Page 1 of 1 · 4 trades